Catalyst Wire Dossier Catalyst Wire Dossier

HyperQure Renal Denervation System

· DeepQure Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HyperQure Renal Denervation System, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension [NA]

See pricing